FilingFirehose · free AI preview
LIGAND PHARMACEUTICALS INC
LGNYZ · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Officer Departure
Ligand Pharmaceuticals filed an 8-K on June 9, 2026, disclosing an officer departure (Items 5.02/5.07), marking one red-flag filing in the past 90 days with zero detected cyber incidents. This personnel change warrants context around timing, replacement plans, and any related compensation impacts on shareholder value. The full $49 Report adds complete 8-K context, 12-month filing history, dilution risk scoring, equity grant analysis, and AI-detected financing signals to assess whether this departure signals operational stress or routine succession.
Want the full 5-section $49 Report on LGNYZ?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.